Polyhydrazides and poly(amide‐hydrazide)s were prepared from two ether‐sulfone‐dicarboxylic acids, 4,4′‐[sulfonylbis(1,4‐phenylene)dioxy]dibenzoic acid and 4,4′‐[sulfonylbis(2,6‐dimethyl‐1,4‐phenylene)dioxy]dibenzoic acid, or their diacyl chlorides with terephthalic dihydrazide, isophthalic dihydrazide, and p ‐aminobenzhydrazide via a phosphorylation reaction or a low‐temperature solution polycondensation. All the hydrazide polymers were found to be amorphous according to X‐ray diffraction analysis. They were readily soluble in polar organic solvents such as N ‐methyl‐2‐pyrrolidone and N,N ‐dimethylacetamide and could afford colorless, flexible, and tough films with good mechanical strengths via solvent casting. These hydrazide polymers exhibited glass‐transition temperatures of 149–207 °C and could be thermally cyclodehydrated into the corresponding oxadiazole polymers in the solid state at elevated temperatures. Although the oxadiazole polymers showed a significantly decreased solubility with respect to their hydrazide prepolymers, some oxadiazole polymers were still organosoluble. The thermally converted oxadiazole polymers had glass‐transition temperatures of 217–255 °C and softening temperatures of 215–268 °C and did not show significant weight loss before 400 °C in nitrogen or air. For a comparative study, related sulfonyl polymers without the ether groups were also synthesized from 4,4′‐sulfonyldibenzoic acid and the hydrazide monomers by the same synthetic routes.
No takes yet. Share an insight, caveat, or question.
Hsiao et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: